BioNTech is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases, and other serious diseases. They are involved in developing multi-specific precision immunotherapies and have a strong focus on IP management.
Focus Areas
Notable Investments
